Diapason Consulting

Blog

Apple

Random Regulatory fact of the day: Apple is the sponsor of four medical devices in Australia. As expected, two are the two features of the Applewatch that are medical devices in Australia (registered in February and March 2021). Two others are gloves and infrared thermometers that Apple registered as importer at the start of the pandemic in early 2020. Technically, Apple started they #healthtech journey in Australia with thermometers and nitrile gloves.

Continue reading

TRIZ

Brilliant example of Innovation. Moving our energy grids away from fossil fuel comes with many challenges, among them the storage of energy at the yearly/seasonal scale. There are several existing solutions already developed, based on different principles. But pushing these solutions further is raising other, new challenges: using more rare materials creates further environmental damage and generate politico-economic incidents. Some tech may be dangerous at large scale, or too costly, or have a too large footprint.

Continue reading

2050 Crossroads

2050 Crossroads A book by Hicham Naim I believe anticipation is a fundamental part of innovation. There are plenty of futurist magazine articles that promise us a life of luxury, comfort and performance thanks to all sorts of new technology developments based on bench prototypes and university lab press releases. This is very common with generalist ’tech’ press, that will cover vehicles and transportation, space travel, housing, leisure etc. Healthtech and medtech are no stranger to this trend (I plead guilty LOL.

Continue reading

Selftech Pioneers

Selftech Pioneers https://events.humanitix.com/diy-loopers-pioneers-of-self-tech Jasmine Schipp will introduce us to the communities of DIY Loopers and share with us her research on their reasons to choose to use DIY systems, how they navigate the challenges, and the future of this movement. After Jasmine’s presentation, Jon Schull, Anthony DiFranco, Renza Scibilia and I will discuss further the place and scope of this movement within the entire diabete-care ecosystem, and its relationships with other communities of DYI makers, open-source advocates and healthtech enthusiasts.

Continue reading

trials

This is particularly relevant for entrepreneurs. The landscape today is not anymore the one in which Elizabeth Holmes was able to pull a “Ana Delvey” on an impressive list of investors to grow her venture to a $10B valued unicorn. Investors today are evidence-driven and data-driven. The promises have to be substanciated with a solid process BEFORE the later series of investment. Even at seed level, there are significant expectations in terms of clinical evidence.

Continue reading

Hello World

Hello there First post. Time to put this website up even if it is not ready yet. Trying out Hugo. Great opportunity to practice my Git chops. Still lots of pages to write - sorry for the “404s” and “coming soons”. I don’t mind some feedback - shoot me an email

Continue reading